Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Equity Ratio: 2020-2025

Historic Equity Ratio for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to 0.59.

  • GeneDx Holdings' Equity Ratio rose 18.30% to 0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59, marking a year-over-year increase of 18.30%. This contributed to the annual value of 0.58 for FY2024, which is 7.40% up from last year.
  • Latest data reveals that GeneDx Holdings reported Equity Ratio of 0.59 as of Q3 2025, which was down 0.96% from 0.60 recorded in Q2 2025.
  • GeneDx Holdings' Equity Ratio's 5-year high stood at 0.70 during Q4 2021, with a 5-year trough of -3.23 in Q2 2021.
  • Over the past 3 years, GeneDx Holdings' median Equity Ratio value was 0.58 (recorded in 2024), while the average stood at 0.57.
  • Its Equity Ratio has fluctuated over the past 5 years, first spiked by 5,657.74% in 2021, then fell by 26.22% in 2022.
  • Quarterly analysis of 5 years shows GeneDx Holdings' Equity Ratio stood at 0.70 in 2021, then decreased by 26.22% to 0.52 in 2022, then rose by 5.37% to 0.54 in 2023, then increased by 7.40% to 0.58 in 2024, then rose by 18.30% to 0.59 in 2025.
  • Its last three reported values are 0.59 in Q3 2025, 0.60 for Q2 2025, and 0.58 during Q1 2025.